Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charles Koob Insider Profile
4 Followers
Charles Koob, Director at MiMedx Group, holds 1.43M shares in MiMedx Group (Ticker: MDXG), holds 756.03K shares in ClearPoint Neuro (Ticker: CLPT).
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+33.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Charles Koob holds in companies
Most Profitable Insider Trade
The most profitable trade made by Charles Koob
Charles Koob's Trading History
MiMedx Group
Oct 05, 2020
Director
Uninformative Buy
174.99K
$10.31M
ClearPoint Neuro
Oct 05, 2017
Director
Uninformative Buy
6.74K
$4.53M
List of latest transactions for each holding click on a transaction to see Charles Koob's performance on stock
You May Also Like
Charles Koob insider profile FAQ
What is the percentage of profitable transactions made by Charles Koob?
The percentage of profitable transactions made by Charles Koob is 100%.
What is the average return per transaction made by Charles Koob?
The average return per transaction made by Charles Koob is 33.90%.
What stocks does Charles Koob hold?
Charles Koob holds: MDXG, CLPT stocks.
What was Charles Koob’s latest transaction?
Charles Koob latest transaction was an Uninformative Buy of $174.99K.
What was Charles Koob's most profitable transaction?
Charles Koob’s most profitable transaction was an Informative Buy of MDXG stock on July 30, 2014. The return on the trade was 57.00%.
What is Charles Koob's role in MiMedx Group?
Charles Koob's role in MiMedx Group is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.